Highlights of the year from our outgoing placement students
Students from our industrial placement scheme for 2020 review their year working in drug discovery at LifeArc
Together we have #invested £18m to establish a #network of #GeneTherapy Innovation Hubs across the UK with help fro… https://t.co/ccfJlWUc36
Industrialising academic-led gene therapies
Sven Kili, Chair of the Coordinating Committee overseeing the creation of the Gene Therapy Innovation Hubs, discusses how Gene Therapy Innovation Hubs will advance promising research into new treatments for patients.
LifeArc and PharmEnable team up to discover novel oral antiviral drugs to treat coronaviruses
Aiming to produce an oral therapeutic with broad applicability across coronaviruses.
Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc
Novartis UK announces companies selected for the Novartis BIOME UK HealthHub 21 Challenge
Kickstart drug repurposing: smashing the roadblocks on the route to patients
How LifeArc aims to support charities, researchers and funders exploring new uses for existing medicines
Proud to be part of the scientific community driving MND research
The status of scientific understanding of MND and the ambition behind creating the joint fund with the MND Association
LifeArc publishes expert advice to support work around repurposing medicines
Guide will support researchers and charities who focus on diseases which have few effective therapies
PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19
£100,000 grant to develop a globally-accessible, oral antiviral as part of the COVID Moonshot initiative
KQ Labs opens applications for health start-ups for its annual accelerator programme
This year's programme delivered by the Francis Crick Institute and funded by LifeArc